Abstract
Depression is the most common mental disorder, affecting a large population worldwide. Of the psychiatric syndromes which present mood disorders, major depressive disorder (MDD) is one of the most severe due to the long periods of depressed mood, somatic symptoms, cognitive disturbances, clinically significant distress and impairment in everyday functioning. The causes of MDD are complex and associated with environmental and biological aspects. Treatment comprises structured forms of psychotherapy and antidepressant medication but remission rates are low and justify the implementation of an alternative effective treatment. Various authors have associated physical exercise with the treatment of depression and different biological and psychological hypotheses have been proposed. Several clinical trials have been performed and, while some authors report no apparent association, the majority of the published data demonstrates a positive effect of physical exercise on both depressive symptoms and Quality of Life (QoL). In this review, the current status of exercise associated treatment of MDD is addressed, relevant data and models are discussed, and an updated view of the current situation is presented.
Keywords: Major depressive disorder, MDD, depression, physical exercise, physical activity, Omega-3 fatty acids, osteoporosis, seasonal effects, homozygotic, multigenic, angiogenic factor, Brain Derived Neurotrophic Factor (BDNF), Monoamine, Endorphin, Thermogenic
Current Psychopharmacology
Title: Physical Exercise and Major Depressive Disorder - Where Do We Stand?
Volume: 1
Author(s): Jorge Mota Pereira, Jorge Silverio, Serafim Carvalho, Joaquim Ramos and Jose Carlos Ribeiro
Affiliation:
Keywords: Major depressive disorder, MDD, depression, physical exercise, physical activity, Omega-3 fatty acids, osteoporosis, seasonal effects, homozygotic, multigenic, angiogenic factor, Brain Derived Neurotrophic Factor (BDNF), Monoamine, Endorphin, Thermogenic
Abstract: Depression is the most common mental disorder, affecting a large population worldwide. Of the psychiatric syndromes which present mood disorders, major depressive disorder (MDD) is one of the most severe due to the long periods of depressed mood, somatic symptoms, cognitive disturbances, clinically significant distress and impairment in everyday functioning. The causes of MDD are complex and associated with environmental and biological aspects. Treatment comprises structured forms of psychotherapy and antidepressant medication but remission rates are low and justify the implementation of an alternative effective treatment. Various authors have associated physical exercise with the treatment of depression and different biological and psychological hypotheses have been proposed. Several clinical trials have been performed and, while some authors report no apparent association, the majority of the published data demonstrates a positive effect of physical exercise on both depressive symptoms and Quality of Life (QoL). In this review, the current status of exercise associated treatment of MDD is addressed, relevant data and models are discussed, and an updated view of the current situation is presented.
Export Options
About this article
Cite this article as:
Mota Pereira Jorge, Silverio Jorge, Carvalho Serafim, Ramos Joaquim and Carlos Ribeiro Jose, Physical Exercise and Major Depressive Disorder - Where Do We Stand?, Current Psychopharmacology 2012; 1 (2) . https://dx.doi.org/10.2174/2211556011201020167
| DOI https://dx.doi.org/10.2174/2211556011201020167 |
Print ISSN 2211-5560 |
| Publisher Name Bentham Science Publisher |
Online ISSN 2211-5579 |
Call for Papers in Thematic Issues
Breakthroughs in Drug Design, Development and Delivery System for the Management of Neuro-Psychiatric Disorders
Neuropsychiatric diseases are one of the main causes of disability, affecting millions of people. Various drugs are used for its treatment, although no effective therapy has been found yet. The blood-brain barrier (BBB) significantly complicates drug delivery to the target cells in the brain tissues. This proposal describes the current ...read more
Novel Psychiatric Classifications: Challenges, Controversies, and Future Directions
Psychiatric classification systems are at a pivotal crossroads. While traditional taxonomies like the DSM and ICD have provided essential frameworks for diagnosing mental disorders, they have also faced longstanding critiques related to their validity. This special issue, Novel Psychiatric Classifications: Challenges, Controversies, and Future Directions, seeks to explore innovative paradigms ...read more
PD-1 Inhibitors in Neuroprotection: Modulating Neurotransmitter Pathways for Therapy
Programmed cell death protein-1 (PD-1) inhibitors, widely recognized for their role in immunotherapy, have recently emerged as potential neuroprotective agents. Beyond their traditional application in oncology, PD-1 inhibitors influence neuroimmune interactions, impacting neurotransmitter pathways critical for maintaining brain homeostasis. Dysregulation of these pathways is implicated in neurodegenerative and neuropsychiatric disorders, ...read more
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Possibilities of Two-Dimensional Gel Electrophoresis in the Understanding of Human Disease
Current Proteomics Lipoprotein-associated Phospholipase A2 and Coronary Heart Disease
Current Pharmaceutical Design Tumor Necrosis Factor Blocking Therapy and Congestive Heart Failure in Patients with Inflammatory Rheumatic Disorders: A Systematic Review
Current Medicinal Chemistry Benefits of Pulmonary Rehabilitation in Patients with COPD with Use and without the Use of Supplemental Oxygen During Exercise
Current Respiratory Medicine Reviews The Effects of Lipid-Regulating Therapy on Haemostatic Parameters
Current Pharmaceutical Design Preclinical Testing of Drug-Induced Proarrhythmia: Value of Transgenic Models
Cardiovascular & Hematological Agents in Medicinal Chemistry Antiplatelet Agents in Cardiology: A Report on Aspirin, Clopidogrel, Prasugrel, and Ticagrelor
Current Pharmaceutical Design Receptor-Binding and Pharmacokinetic Properties of Dopaminergic Agonists
Current Topics in Medicinal Chemistry Vitamin Bs, One Carbon Metabolism and Prostate Cancer
Mini-Reviews in Medicinal Chemistry Vascular Effects of Estrogenic Menopausal Hormone Therapy
Reviews on Recent Clinical Trials Mexiletine Metabolites: A Review
Current Medicinal Chemistry Targeting MCP-1 to Reduce Vascular Complications of Obesity
Recent Patents on Cardiovascular Drug Discovery Tea and Health: Studies in Humans
Current Pharmaceutical Design Role of the Autonomic Nervous System and Neuropeptides in the Development of Obesity in Humans: Targets for Therapy?
Current Pharmaceutical Design Pathophysiology of Myocardial Infarction and Acute Management Strategies
Cardiovascular & Hematological Agents in Medicinal Chemistry Feasibility of Weight-based Tube Voltage and Iodine Delivery Rate for Coronary Artery CT Angiography
Current Medical Imaging Thyroid Function and Obesity: From Mechanisms to the Benefits of Levothyroxine in Obese Patients
Endocrine, Metabolic & Immune Disorders - Drug Targets A Review of Recent Patents on the Protozoan Parasite HSP90 as a Drug Target
Recent Patents on Biotechnology Renal Tubular Acidosis
Current Pediatric Reviews Interview: Dr. Muin J. Khoury Discusses the Future of Public Health Genomics and why it Matters for Personalized Medicine and Global Health
Current Pharmacogenomics and Personalized Medicine





